Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Carboxy Methyl Lysine anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement Carboxy Methyl Lysine dans EIA, WB, IHC (fro), IF et IHC (p). Il présente une réactivité envers .
N° du produit ABIN1105660

Aperçu rapide pour Carboxy Methyl Lysine anticorps (ABIN1105660)

Antigène

Voir toutes Carboxy Methyl Lysine (CML) Anticorps
Carboxy Methyl Lysine (CML)

Hôte

  • 1
  • 1
Souris

Clonalité

  • 1
  • 1
Monoclonal

Conjugué

  • 2
Cet anticorp Carboxy Methyl Lysine est non-conjugé

Application

Enzyme Immunoassay (EIA), Western Blotting (WB), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone

CML26
  • Réactivité croisée (Details)

    Species reactivity (tested):Human, Multispecies cross reactant.

    Purification

    Protein G Chromatography

    Immunogène

    Carboxy Methyl Lysine (CML)-KLH

    Isotype

    IgG1
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    0.1 mg/mL

    Buffer

    PBS, 0.02 % Sodium Azide, 0.1 % BSA

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Store undiluted at 2-8 °C.
  • Antigène

    Carboxy Methyl Lysine (CML)

    Autre désignation

    Carboxy Methyl Lysine

    Classe de substances

    Amino Acid

    Sujet

    CML is known to be formed from the oxidation of both carbohydrates and lipids. This makes CML a biomarker of general oxidative stress. Carboxymethyl-lysine (CML) is a well-characterized glycoxidation product that accumulates in tissues with age, and its rate of accumulation is accelerated in diabetes. Glycoxidation products are a subset of advanced glycation endproducts (AGEs) that are formed by the nonenzymatic glycation and subsequent irreversible oxidation of proteins. Oxidative stress and protein modification have been implicated in the pathogenesis of the chronic complications of diabetes, including nephropathy and atherosclerosis. The accumulation of CML in long-lived tissue such as skin collagen reflects oxidative stress over an extended period of the life-span, and has been shown to be greater in patients with diabetic complications than those without complications.Synonyms: CML, Carboxymethyl-lysine
Vous êtes ici:
Chat with us!